
An artificial neuroimmune axis fueled by glucose for metabolic control
Lazar, MA How Obesity Causes Diabetes: It’s Not a Story. Science 307373-375 (2005).
Tracey, KJ The inflammatory reflex. Nature 420853-859 (2002).
Abel, ED et al. Diabetes mellitus – progress and opportunities in an evolving epidemic. Cell 1873789-3820 (2024).
Yao, G. et al. Effective weight control via an implanted self-powered vagus nerve stimulation device. Nat. Common. 95349 (2018).
Mirza, KB, Golden, CT, Nikolic, K. & Toumazou, C. Closed-loop implantable therapeutic neuromodulation systems based on neurochemical monitoring. In front. Neuroscience. 13808 (2019).
Kawana, Y. et al. Optogenetic stimulation of vagal nerves for increased glucose-stimulated insulin secretion and beta cell proliferation. Nat. Biomede. Eng. 8808-822 (2024).
Rohm, TV, Meier, DT, Olefsky, JM & Donath, MY Inflammation in obesity, diabetes and related disorders. Immunity 5531-55 (2022).
Shaikh, SR, Beck, MA, Alwarawrah, Y. & MacIver, NJ Emerging mechanisms of obesity-associated immune dysfunction. Nat. Reverend Endocrinol. 20136-148 (2024).
Le Thuc, O. & Garcia-Caceres, C. Obesity-induced inflammation: connecting the periphery to the brain. Nat. Metab. 61237-1252 (2024).
Katsarou, A. et al. Type 1 diabetes mellitus. Nat. Reverend Dis. Primers 317016 (2017).
DeFronzo, RA et al. Type 2 diabetes mellitus. Nat. Reverend Dis. Primers 115019 (2015).
Pavlov, VA & Tracey, KJ The vagus nerve and the inflammatory reflex linking immunity and metabolism. Nat. Reverend Endocrinol. 8743-754 (2012).
Cotero, V. et al. Stimulation of the hepatoportal nerve plexus with focused ultrasound restores glucose homeostasis in diabetic mice, rats and pigs. Nat. Biomede. Eng. 6683-705 (2022).
Lackey, DE & Olefsky, JM Regulation of metabolism by the innate immune system. Nat. Reverend Endocrinol. 1215-28 (2016).
Borovikova, LV et al. Stimulation of the vagus nerve attenuates the systemic inflammatory response to endotoxin. Nature 405458-462 (2000).
Sha, B. et al. Doping-induced assembly interface for non-invasive local and systemic immunomodulation in vivo. Proc. Natl Acad. Sci. USA 120e2306777120 (2023).
Kotb, MA et al. Cross-sectional area of the vagus nerve on ultrasound in patients with type 2 diabetes. Medicine 102e36768 (2023).
Kim, Y. et al. A bioinspired flexible organic artificial afferent nerve. Science 360998-1003 (2018).
Wang, W. et al. Neuromorphic sensorimotor loop embodied by a soft, low-voltage, monolithicly integrated electronic skin. Science 380735-742 (2023).
Ottaviani, MM, Vallone, F., Micera, S. & Recchia, FA Closed-loop vagus nerve stimulation for the treatment of cardiovascular diseases: state of the art and future directions. In front. Cardiovascular. Med. 9866957 (2022).
Sun, FT & Morrell, MJ Closed-loop neurostimulation: clinical experience. Neurotherapeutics 11553-563 (2014).
Scangos, KW et al. Closed-loop neuromodulation in an individual with treatment-resistant depression. Nat. Med. 271696-1700 (2021).
Oh, S. et al. Bioelectronic implantable devices for recording physiological signals and closed-loop neuromodulation. Av. Function. Master. 342403562 (2024).
Ben-Menachem, E. Vagus nerve stimulation, side effects and long-term safety. J. Clin. Neurophysiol. 18415-418 (2001).
Bai, J. et al. Coin-sized, fully integrated, minimally invasive continuous glucose monitoring system based on organic electrochemical transistors. Sci. Av. 10EADL1856 (2024).
Gao, W. et al. Fully integrated wearable sensor networks for multiplexed in situ sweat analysis. Nature 529509-514 (2016).
Ashrafi, G. & Ryan, TA Glucose metabolism in nerve endings. Curr. Notice. Neurobiol. 45156-161 (2017).
Liu, Y. et al. Morphing electronics enable neuromodulation in growing tissues. Nat. Biotechnology. 381031-1036 (2020).
Chen, J. et al. Glucose-oxidase-type catalytic mechanism of noble metal nanozymes. Nat. Common. 123375 (2021).
Wu, J. & Yang, H. Platinum-based oxygen reduction electrocatalysts. Acc. Chemical. Res. 461848-1857 (2013).
Maity, D., Guha Ray, P., Buchmann, P., Mansouri, M. & Fussenegger, M. Glucose-powered metabolic fuel cell for self-sufficient bioelectronics. Av. Maître. 35e2300890 (2023).
De la Paz, E. et al. A self-powered ingestible wireless biosensing system for real-time in situ monitoring of gastrointestinal tract metabolites. Nat. Common. 137405 (2022).
Lee, D. et al. Fully implantable enzymatic fuel biofuel cell and brain stimulator operating in birds via wireless communication. Biosens. Bioelectron. 171112746 (2021).
Kang, J. et al. Durable, water-resistant self-healing elastomer for robust electronic skin. Av. Maître. 30e1706846 (2018).
Friedel, M. et al. Opportunities and challenges in the diagnostic utility of dermal interstitial fluid. Nat. Biomede. Eng. 71541-1555 (2023).
Sacks, DB et al. Guidelines and recommendations for laboratory tests in the diagnosis and management of diabetes mellitus. Clin. Chemical. 48436-472 (2002).
Furman, BL Streptozotocin-induced diabetic models in mice and rats. Curr. Protocol. Pharmacol. 705.47.41-45.47.20 (2015).
Wang, H. et al. The α7 subunit of the nicotinic acetylcholine receptor is a critical regulator of inflammation. Nature 421384-388 (2003).
Pavlov, VA, Wang, H., Czura, CJ, Friedman, SG & Tracey, KJ The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol. Med. 9125-134 (2003).
Van Goethem, NP et al. Antagonism of α7 nicotinic receptors with methyllycaconitine (mla) potentiates receptor activity and memory acquisition. Cellular signal. 62109338 (2019).
Xu, J., Li, P., Wang, G.E., Ye, D. and Tang, X. Inhibition of 7nachr by methyllycaconitine citrate promotes cellular pyroptosis by triggering the polyol pathway in cervical cancer cells. Biocell 48283-291 (2024).
Waise, TMZ, Dranse, HJ & Lam, TKT The metabolic role of vagal afferent innervation. Nat. Reverend Gastroenterol. Hepatol. 15625-636 (2018).
Assaad, H. et al. Analysis of energy expenditure in diet-induced obese rats. In front. Biosci. 19967-985 (2014).
Martínez-Reyes, I. & Chandel, NS Control of mitochondrial tca cycle metabolites…
Gn Health